1. Ludwig, R.J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K.,McLachlan, S.M., Komorowski, L., Luo, J., Cabral-Marques, O.,Hammers, C.M., et al. (2017). Mechanisms of autoantibody-induced pathology. Front. Immunol. 8, 603.2. Yamamoto, K., and Shlomchik, M. (2010). Autoimmunity. Curr. Opin. Immunol. 22, 695–697.3. Guia, S., Fenis, A., Vivier, E., and Narni-Mancinelli, E. (2018). Activating and inhibitory receptors expressed on innate lymphoid cells. Semin. Immunopathol. 40, 331–341.4. Pincetic, A., Bournazos, S., DiLillo, D.J., Maamary, J., Wang, T.T., Dahan, R., Fiebiger, B.M., and Ravetch, J.V. (2014). Type I and type II Fc receptors regulate innate and adaptive immunity. Nat. Immunol. 15, 707–716.5. Hartung, H.P., Mouthon, L., Ahmed, R., Jordan, S., Laupland, K.B., and Jolles, S. (2009). Clinical applications of intravenous immunoglobulins (IVIg)–beyond immunodeficiencies and neurology. Clin.Exp.Immunol. 158, 23–33.6. Massoud, A.H., Yona, M., Xue, D., Chouiali, F., Alturaihi, H., Ablona, A., Mourad, W., Piccirillo, C.A., and Mazer, B.D. (2014). Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J. Allergy Clin.Immunol. 133. 853-63.e5.